# Kadcyla market is demonstrating robust growth, driven by several critical factors.

*biotech · news · 2026-05-07 · GlobeNewswire*

## Key points

- Asia-Pacific is the fastest-growing region in the Kadcyla market, outpacing North America’s growth rate.
- Tariffs are incentivizing regional manufacturing of ADCs, impacting supply chains and market pricing for Kadcyla.
- Kadcyla market segmentation includes adult male and pediatric patients, not just adult females.
- Home healthcare is an expanding end-user segment for Kadcyla’s administration beyond traditional hospital settings.

**Companies:** F. Hoffmann-La Roche Ltd
**Countries:** USA, Canada, China, Germany

[Read the full story on GlobeNewswire](https://www.globenewswire.com/news-release/2026/05/07/3290165/28124/en/kadcyla-f-hoffmann-la-roche-market-research-report-2026-epidemiology-pipeline-analysis-market-insights-forecasts-2020-2025-2025-2030f-2035f.html)

---

Canonical: https://newsio.io/n/3ad61959-1790-478a-bf92-ad24f172733b/kadcyla-market-is-demonstrating-robust-growth-driven-by-several-critical-factors
Summarized by Newsio from GlobeNewswire. https://newsio.io/how-it-works